Some aspects need to be considered in assessment and treatment of sarcopenia

Tugba Erdogan, Gulistan Bahat Department of Internal Medicine, Division of Geriatrics, Istanbul University, Istanbul Medical School, Istanbul, TurkeyWe have read the review article by Ilaria Liguori et al1 with great interest. In this article, authors aimed to review sarcopenia in terms of assessme...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Erdogan T, Bahat G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	sarcopenia Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/b9dc6d98bde142fa8a19e19fa549cf37
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b9dc6d98bde142fa8a19e19fa549cf37
record_format	dspace
spelling	oai:doaj.org-article:b9dc6d98bde142fa8a19e19fa549cf372021-12-02T00:32:18ZSome aspects need to be considered in assessment and treatment of sarcopenia1178-1998https://doaj.org/article/b9dc6d98bde142fa8a19e19fa549cf372018-07-01T00:00:00Zhttps://www.dovepress.com/some-aspects-need-to-be-considered-in-assessment-and-treatment-of-sarc-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Tugba Erdogan, Gulistan Bahat Department of Internal Medicine, Division of Geriatrics, Istanbul University, Istanbul Medical School, Istanbul, TurkeyWe have read the review article by Ilaria Liguori et al1 with great interest. In this article, authors aimed to review sarcopenia in terms of assessment of its burden and strategies to improve outcomes. We have some comments that would contribute on this extensive review. Authors reported that the diagnosis of sarcopenia requires the presence of both low muscle mass and low muscle function. Authors defined low muscle function as gait speed lower than 0.8 m/s and/or a grip strength lower than 26–30 kg for men and 16–20 kg for women. However, it should be noted that European Working Group on Sarcopenia in Older People (EWGSOP) recommends use of normative data of the study population for muscle mass and muscle strength cutoff points. After EWGSOP publication, population-specific cutoff values, including the Turkish and Korean population, have been published and better to be included in a paper aimed to review sarcopenia in this context.2View the original paper by Liguori and colleagues.Erdogan TBahat GDove Medical PressarticlesarcopeniaGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 13, Pp 1231-1232 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	sarcopenia Geriatrics RC952-954.6
spellingShingle	sarcopenia Geriatrics RC952-954.6 Erdogan T Bahat G Some aspects need to be considered in assessment and treatment of sarcopenia
description	Tugba Erdogan, Gulistan Bahat Department of Internal Medicine, Division of Geriatrics, Istanbul University, Istanbul Medical School, Istanbul, TurkeyWe have read the review article by Ilaria Liguori et al1 with great interest. In this article, authors aimed to review sarcopenia in terms of assessment of its burden and strategies to improve outcomes. We have some comments that would contribute on this extensive review. Authors reported that the diagnosis of sarcopenia requires the presence of both low muscle mass and low muscle function. Authors defined low muscle function as gait speed lower than 0.8 m/s and/or a grip strength lower than 26–30 kg for men and 16–20 kg for women. However, it should be noted that European Working Group on Sarcopenia in Older People (EWGSOP) recommends use of normative data of the study population for muscle mass and muscle strength cutoff points. After EWGSOP publication, population-specific cutoff values, including the Turkish and Korean population, have been published and better to be included in a paper aimed to review sarcopenia in this context.2View the original paper by Liguori and colleagues.
format	article
author	Erdogan T Bahat G
author_facet	Erdogan T Bahat G
author_sort	Erdogan T
title	Some aspects need to be considered in assessment and treatment of sarcopenia
title_short	Some aspects need to be considered in assessment and treatment of sarcopenia
title_full	Some aspects need to be considered in assessment and treatment of sarcopenia
title_fullStr	Some aspects need to be considered in assessment and treatment of sarcopenia
title_full_unstemmed	Some aspects need to be considered in assessment and treatment of sarcopenia
title_sort	some aspects need to be considered in assessment and treatment of sarcopenia
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/b9dc6d98bde142fa8a19e19fa549cf37
work_keys_str_mv	AT erdogant someaspectsneedtobeconsideredinassessmentandtreatmentofsarcopenia AT bahatg someaspectsneedtobeconsideredinassessmentandtreatmentofsarcopenia
_version_	1718403702530768896

Some aspects need to be considered in assessment and treatment of sarcopenia

Ejemplares similares